BiBBInstruments AB

Equities

BIBB

SE0010102095

Advanced Medical Equipment & Technology

End-of-day quote NORDIC GROWTH MARKET 06:00:00 2024-05-14 pm EDT 5-day change 1st Jan Change
4.78 SEK +0.42% Intraday chart for BiBBInstruments AB +2.80% +51.27%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
BiBBInstruments AB Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
BiBBInstruments Secures Patent for EndoDrill in India MT
BiBBInstruments AB Announces Successful Clinical Pilot Study with EndoDrill GI Published in Peer Reviewed Scientific Journal CI
BiBBInstruments Reports First Clinical Procedures in Sweden with Endoscopic Biopsy Instrument MT
Bibbinstruments AB First Clinical Tissue Acquisition Procedures with Endodrill® Gi At Karolinska University Hospital in Stockholm Have Been Successfully Performed CI
BiBBInstruments Wins Japanese Patent for Biopsy System MT
BiBBInstruments AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
BiBBInstruments AB Reports Earnings Results for the Full Year Ended December 31, 2023 CI
BiBBInstruments Obtains European CE Certification for Endoscopic Biopsy Instrument MT
BiBBInstruments Reports First US Clinical Procedures with Core Needle Biopsy System MT
Bibbinstruments AB Announces First US Clinical Cases Successfully Conducted with Endodrill GI CI
BiBBInstruments AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
BiBBInstruments Secures European Patent for Cancer Diagnostic Product MT
Bibb Receives Approval of Two Patents in Europe for Endodrill CI
BiBBInstruments AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
BiBBInstruments AB Reports Positive Results from Clinical Pilot Study with EndoDrill URO CI
BiBBInstruments AB Reports Earnings Results for the Full Year Ended December 31, 2022 CI
BiBBInstruments AB Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
BiBBInstruments AB Receives Another Intention to Grant Notice for EndoDrill in Europe CI
BiBBInstruments AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
BiBBInstruments AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
BiBBInstruments Aims for US Market Entry in 2023 CI
BiBBInstruments Develops the CE-Marked Electromechanical Biopsy Instruments for Endoscopic Use CI
BiBBInstruments AB Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
BiBBInstruments AB announced that it has received SEK 21.6 million in funding from Tibia Konsult Aktiebolag, Creades AB, Gainbridge Capital AB, Aktia Fund Management Company Ltd CI
Chart BiBBInstruments AB
More charts
BibbInstruments AB is a Sweden-based medical technology company. It develops and sales biopsy instruments, which are based on technology platform EndoDrill. The drill function enables early cancer diagnosis, especially in deep skin tissues. The portfolio includes EndoDrill GI Upper for stomach biopsy, EndoDrill GI Lower for intestinal biopsy, EndoDrill GI Lung for lung biopsy, EndoDrill Therapy to pass displacements in different organs for placement of conductors, balloons and stents for treatment, EndoDrill Needle for breasts biopsy, as well as EndoDrill Model X for multiple areas and falls under independent research project. Products are distributed to hospitals with endoscopy specialists’ centers and surgical wards. The Company’s primary distribution focus is Scandinavian countries.
More about the company
  1. Stock Market
  2. Equities
  3. BIBB Stock
  4. News BiBBInstruments AB
  5. BiBBInstruments Secures European Patent for Cancer Diagnostic Product
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW